ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,142Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 262

$351K Total Retail Price of All Prescriptions

Rank: 64 out of 262

352 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 352 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 352 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,300 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
SIMVASTATIN 321 302 1 1
OMEPRAZOLE 308 257 2 5
LEVOTHYROXINE SODIUM 261 240 3 2
METOPROLOL SUCCINATE 254 245 4 11
LISINOPRIL 249 213 5 3
AMLODIPINE BESYLATE 203 193 6 6
FUROSEMIDE 186 182 7 4
POTASSIUM CHLORIDE 167 153 8 10
SERTRALINE HCL 145 141 9 14
WARFARIN SODIUM 137 136 10 12
HYDROCODONE-ACETAMINOPHEN 121 105 S3 11 15
LOSARTAN POTASSIUM 110 102 12 17
SPIRONOLACTONE 107 93 13 58
ATORVASTATIN CALCIUM 103 94 14 13
METOPROLOL TARTRATE 97 90 15 8
TAMSULOSIN HCL 96 95 16 25
METFORMIN HCL 89 69 17 9
FAMOTIDINE 89 89 17 65
SPIRONOLACTONE-HCTZ 87 78 19 150
TRAZODONE HCL 87 62 19 36
FLUTICASONE PROPIONATE 85 64 21 48
PAROXETINE HCL 82 66 22 56
GABAPENTIN 81 58 23 19
ADVAIR DISKUS 77 45 24 34
MIRTAZAPINE 75 73 25 35
TRIAMTERENE-HCTZ 72 72 26 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 69 27 24
DONEPEZIL HCL 66 66 28 23
ALLOPURINOL 64 47 29 22
FENOFIBRATE 61 39 30 77
CLOPIDOGREL 60 58 31 38
PANTOPRAZOLE SODIUM 58 51 32 52
ATENOLOL 57 56 33 16
TORSEMIDE 57 51 33 203
BISOPROLOL FUMARATE 53 53 35 153
PLAVIX 52 52 36 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.